InMed Pharmaceuticals Inc (INM) earnings · rev $4.9M
These earnings events as JSON? API free 100/dayInMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
This INM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
When the next INM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 7.5% from 2024-06-30 to 2025-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full INM research stays on the stock page; the tape stays on the quote page.
INM earnings FAQ
What are INM's latest revenue and net income?
Latest cached InMed Pharmaceuticals Inc (INM) revenue for Jun 30, 2025 was $4.9M. Net income was -$8.2M. Statements: https://lician.com/financials/inm
What is INM's latest diluted EPS?
Latest cached InMed Pharmaceuticals Inc (INM) diluted EPS for Jun 30, 2025 was -$8.36.
What period does the latest INM earnings print cover?
The latest cached InMed Pharmaceuticals Inc (INM) earnings print covers Jun 30, 2025. The prior cached period on this page is Jun 30, 2024.
How did INM revenue change from the prior cached period?
Cached InMed Pharmaceuticals Inc (INM) revenue was up 7.5% from $4.6M (Jun 30, 2024) to $4.9M (Jun 30, 2025). Statements: https://lician.com/financials/inm
Where are INM earnings listed?
Cached earnings facts for InMed Pharmaceuticals Inc (INM) are listed at https://lician.com/earnings/inm. Statements: https://lician.com/financials/inm
Not investment advice.